Integrative analyses prioritize GNL3 as a risk gene for bipolar disorder

Qingtuan Meng,Le Wang,Rujia Dai,Jiawen Wang,Zongyao Ren,Sihan Liu,Yan Xia,Yi Jiang,Fangyuan Duan,Kangli Wang,Chunyu Liu,Chao Chen

DOI: https://doi.org/10.1038/s41380-020-00866-5

IF: 11

2020-08-21

Molecular Psychiatry

Abstract:Genome-wide association studies (GWASs) have identified numerous single nucleotide polymorphisms (SNPs) associated with bipolar disorder (BD), but what the causal variants are and how they contribute to BD is largely unknown. In this study, we used FUMA, a GWAS annotation tool, to pinpoint potential causal variants and genes from the latest BD GWAS findings, and performed integrative analyses, including brain expression quantitative trait loci (eQTL), gene coexpression network, differential gene expression, protein-protein interaction, and brain intermediate phenotype association analysis to identify the functions of a prioritized gene and its connection to BD. Convergent lines of evidence prioritized protein-coding gene <i>G Protein Nucleolar 3</i> (<i>GNL3</i>) as a BD risk gene, with integrative analyses revealing <i>GNL3</i>'s roles in cell proliferation, neuronal functions, and brain phenotypes. We experimentally revealed that BD-related eQTL SNPs rs10865973, rs12635140, and rs4687644 regulate <i>GNL3</i> expression using dual luciferase reporter assay and CRISPR interference experiment in human neural progenitor cells. We further identified that <i>GNL3</i> knockdown and overexpression led to aberrant neuronal proliferation and differentiation, using two-dimensional human neural cell cultures and three-dimensional forebrain organoid model. This study gathers evidence that BD-related genetic variants regulate <i>GNL3</i> expression which subsequently affects neuronal proliferation and differentiation.

biochemistry & molecular biology,neurosciences,psychiatry